WebApr 13, 2024 · By Natalie Grover and Yadarisa Shabong. (Reuters) - Britain's GlaxoSmithKline sought to bolster its cancer business on Wednesday by agreeing a $1.9 billion deal to buy … WebApr 10, 2024 · Shannon R. Morris, M.D., Ph.D., promoted to Chief Medical Officer Chandra D. Lovejoy promoted to Chief Regulatory Affairs Officer SAN DIEGO, April 10,...
Erasca Strengthens Clinical and Regulatory Leadership
WebMay 15, 2012 · Sierra Oncology acquired by GlaxoSmithKline . Sierra Oncology . GlaxoSmithKline . Apr 13, 2024 . 3. Europharm Holding SA acquired by GlaxoSmithKline . ... save to custom lists or to Salesforce, and get notified when new companies, people, or deals meet your search criteria. START FREE TRIAL WebApr 13, 2024 · UPDATED Wed, Apr 13, 2024 - 3:55 PM. [LONDON] GlaxoSmithKline (GSK) agreed to buy biotech company Sierra Oncology for US$1.9 billion as the UK drugmaker … max and emme muniz
GSK acquires US-based Sierra Oncology for $1.9bn
WebApr 13, 2024 · Cambridge, UK, 13 April 2024 – Sareum Holdings plc (AIM: SAR), the specialist drug development company, notes that Sierra Oncology, Inc (“Sierra”), the licence holder for SRA737 (a novel Chk1 inhibitor), has agreed to be acquired by GlaxoSmithKline plc (“GSK”) for US$1.9 billion in cash. The transaction is expected to close in the ... WebApr 13, 2024 · ISTANBUL . GlaxoSmithKline (GSK) acquired US-based biopharmaceutical Sierra Oncology for £1.5 billion ($1.9 billion), according to a joint press release on Wednesday. Web2 days ago · Momelotinib is the first inhibitor of Janus kinase 1 (JAK1) and JAK2 shown to also inhibit activin A receptor type 1 (ACVR1), a key regulator of iron … max and emmy